Key references: Contraception in obesity

Berenson AB, Rahman M. Changes in weight, total fat, percent body fat, and central-to-peripheral fat ratio associated with injectable and oral contraceptive use. Am J Obstet Gynecol 2009;200(3):329 e1–8. https://www.ncbi.nlm.nih.gov/pubmed/19254592
Bonny AE, Secic M, Cromer B. Early weight gain related to later weight gain in adolescents on depot medroxyprogesterone acetate. Obstet Gynecol 2011;117(4):793–7. https://www.ncbi.nlm.nih.gov/pubmed/21422849
Clark MK, Sowers M, Levy B, Nichols S. Bone mineral density loss and recovery during 48 months in first-time users of depot medroxyprogesterone acetate. Fertil Steril 2006;86(5):1466–74. https://www.ncbi.nlm.nih.gov/pubmed/16996507
Edelman AB, Cherala G, Blue SW, Erikson DW, Jensen JT. Impact of obesity on the pharmacokinetics of levonorgestrel-based emergency contraception: single and double dosing. Contraception 2016;94(1):52–7. https://www.ncbi.nlm.nih.gov/pubmed/27000996
Festin MPR, Peregoudov A, Seuc A, Kiarie J, Temmerman M. Effect of BMI and body weight on pregnancy rates with LNG as emergency contraception: analysis of four WHO HRP studies. Contraception 2017;95(1):50–4. https://www.ncbi.nlm.nih.gov/pubmed/27527670
Gallo MF, Lopez LM, Grimes DA, Carayon F, Schulz KF, Helmerhorst FM. Combination contraceptives: effects on weight. Cochrane Database Syst Rev 2014;(1):CD003987. https://www.ncbi.nlm.nih.gov/pubmed/24477630
Horton LG, Simmons KB, Curtis KM. Combined hormonal contraceptive use among obese women and risk for cardiovascular events: A systematic review. Contraception 2016;94(6):590–604. https://www.ncbi.nlm.nih.gov/pubmed/27263039
Jatlaoui TC, Curtis KM. Safety and effectiveness data for emergency contraceptive pills among women with obesity: a systematic review. Contraception 2016;94(6):605–11. https://www.ncbi.nlm.nih.gov/pubmed/27234874
Le YC, Rahman M, Berenson AB. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol 2009;114(2 Pt 1):279–84. https://www.ncbi.nlm.nih.gov/pubmed/19622988
Lopez LM, Grimes DA, Chen-Mok M, Westhoff C, Edelman A, Helmerhorst FM. Hormonal contraceptives for contraception in overweight or obese women. Cochrane Database Syst Rev 2010;(7):CD008452. https://www.ncbi.nlm.nih.gov/pubmed/20614470
Natavio M, Stanczyk FZ, Molins EAG, Nelson A, Jusko WJ. Pharmacokinetics of the 1.5 mg levonorgestrel emergency contraceptive in women with normal, obese and extremely obese body mass index. Contraception 2019;99(5):306–11. https://www.ncbi.nlm.nih.gov/pubmed/30703352
Praditpan P, Hamouie A, Basaraba CN, Nandakumar R, Cremers S, Davis AR, et al. Pharmacokinetics of levonorgestrel and ulipristal acetate emergency contraception in women with normal and obese body mass index. Contraception 2017;95(5):464–9. https://www.ncbi.nlm.nih.gov/pubmed/28126541
The Faculty of Sexual & Reproductive Healthcare (FSRH). UK medical eligibility criteria (UKMEC) for contraceptive use. London: FSRH; 2016 (Amended 2019). https://www.fsrh.org/standards-and-guidance/uk-medical-eligibility-criteria-for-contraceptive-use-ukmec/
The Faculty of Sexual & Reproductive Healthcare (FSRH). FSRH guideline: Emergency contraception. London: FSRH; 2017. https://www.fsrh.org/standards-and-guidance/current-clinical-guidance/emergency-contraception/
The Faculty of Sexual & Reproductive Healthcare (FSRH) . FSRH guideline: Overweight, obesity & contraception. London: FSRH; 2019. https://www.fsrh.org/standards-and-guidance/documents/fsrh-clinical-guideline-overweight-obesity-and-contraception/
The Faculty of Sexual & Reproductive Healthcare (FSRH) Clinical Effectiveness Unit. FSRH CEU statement: Contraception and weight gain. Edinburgh: FSRH; 2019. https://www.fsrh.org/standards-and-guidance/documents/fsrh-ceu-statement-contraception-and-weight-gain-august-2019/
Zuurbier SM, Arnold M, Middeldorp S, Broeg-Morvay A, Silvis SM, Heldner MR, et al. Risk of cerebral venous thrombosis in obese women. JAMA Neurol 2016;73(5):579–84. https://www.ncbi.nlm.nih.gov/pubmed/26974867